It looks like everyone has figured out that swine flu was more of a media pandemic rather than a disease or viral pandemic. Had this been November as flu season was starting, that might have been a bigger deal. We have seen substantial pullbacks after the massive gains seen in the speculative swine flu stocks. Novavax, Inc. (NASDAQ: NVAX), Generex Biotechnology Corp. (NASDAQ: GNBT), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Pure Bioscience (NASDAQ: PURE), Vical Inc (NASDAQ: VICL), Meridian Bioscience Inc. (NASDAQ: VIVO), and AVI BioPharma Inc. (NASDAQ: AVII) have all begun their overbought roll-over.
Read More
RSS Updates
Email Updates

